Tech Company Financing Transactions
AdJane Funding Round
AdJane, operating out of Delft, secured $2.6 million in investment from Carb-X.
Transaction Overview
Company Information
Company Status
Private & Independent
Industry
Life Sciences
Mailing Address
Thijsseweg 11
Delft, 2629 JA
The Netherlands
Delft, 2629 JA
The Netherlands
Phone
Undisclosed
Website
Email Address
Overview
AdJane is a clinical-stage vaccine platform company focused on pandemic preparedness and global health. Our approach is platform-driven: we develop and apply a scalable vaccine technology that can be selectively partnered with to accelerate global health impact. Our next-generation platform has been scientifically developed over 30 years by Dutch governmental institutions. AdJane has consolidated this extensive scientific development history and advanced the platform to operational readiness for antigen display and adjuvant applications.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chairman
Gina van der Werf
Browse more venture capital transactions:
Prev: 4/27/2026: Vinted venture capital transaction
Next: 4/28/2026: Lighthouse Pharmaceuticals venture capital transaction
Share this article
Where The Data Comes From
We report on every notable VC transaction. VC investment data records on this site are derived from news reports and company announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs